Magnesium Sulfate Injection, Solution
Product Images NDC 63323-642

5 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Magnesium Sulfate (NDC 63323-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mag05 0000 01

FDA Label Image

Mag05 0000 02

Mag05 0000 02
Label for Magnesium Sulfate Injection, USP 50% (500 mg/mL) by Fresenius Kabi USA, LLC. The 20 mL single dose vial is indicated for intramuscular or intravenous use and must be diluted before intravenous administration. The label includes sterility and storage information with a barcode and NDC 63323-642-01.*
FDA Label Image

Mag05 0000 03

Mag05 0000 03
Magnesium Sulfate Injection, USP 500 mg/mL (50%) in a solution form. The label indicates 10 grams per 20 mL (500 mg/mL) in single-dose vials, 25 vials per package. It is for intramuscular or intravenous use, with a warning that it must be diluted before intravenous use. The product is preservative free and manufactured by Fresenius Kabi USA, LLC. Storage and usage instructions are provided on the label.*
FDA Label Image

Mag05 0000 04

Mag05 0000 04
Label for Magnesium Sulfate Injection, USP 50% (500 mg per mL) in a 50 mL single-dose vial by Fresenius Kabi USA, LLC. The label states this injection is for intramuscular or intravenous use, must be diluted before intravenous use, is preservative-free, and includes storage instructions at 20° to 25°C. It also details the composition per mL and cautions to discard unused portions.*
FDA Label Image

Mag05 0000 05

Mag05 0000 05
Label for Magnesium Sulfate Injection, USP 50% (500 mg per mL) in 25 grams per 50 mL single-dose vials. Labeled for intramuscular or intravenous use with a warning to dilute before intravenous use. The product is preservative-free and manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.